Aulin Sherry
Former officer at XENE
- Sold, on record
- $1.4M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Dec 18, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- XENEXenon Pharmaceuticals Inc.Former officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
2
Unusual
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 4 sale XENEUnusualSep 2, 2022 2022
Sold 15,355 shares at $39.57 ($608k)
Aulin Sherry, Chief Financial Officer
Sold 100% of holdings ($608k position)0 shares leftFirst sale on recordFiling
- 2 Form 144 notice XENENoticeDec 18, 2024 +838 days
Filed to sell 18,709 shares ($771k)
Aulin Sherry, Officer
No 10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale XENEUnusualDec 18, 2024 same day
Sold 18,709 shares at $41.21 ($771k)
Aulin Sherry, Chief Financial Officer
No 10b5-1 planSold 100% of holdings ($771k position)0 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 144 notice XENENoticeSep 19, 2025 +275 days
Filed to sell 2,548 shares ($94k)
Aulin Sherry, Former officer
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2025 | Sep 19, 2025 | XENE | Former officer | Form 144 notice | 2,548 | $94k | Notice | SEC | |
| Dec 18, 2024 | Dec 19, 2024 | XENE | Chief Financial Officer | Form 4 sale | 18,709 | $771k | 100.0% | Unusual | SEC |
| Dec 18, 2024 | Dec 18, 2024 | XENE | Officer | Form 144 notice | 18,709 | $771k | Notice | SEC | |
| Sep 2, 2022 | Sep 7, 2022 | XENE | Chief Financial Officer | Form 4 sale | 15,355 | $608k | 100.0% | Unusual | SEC |